Patients with metastatic GIST research hub

LENVAGIST - A multicentre, comparative, placebo-controlled, double-blinded, phase II study of the efficacy of lenvatinib in patients with locally advanced or metastatic GIST after failure of imatinib and sunitinib

This study is testing a new medicine called lenvatinib (LENVIMA) for people with advanced GIST cancer who haven't responded to previous treatments like imatinib and sunitinib. Researchers want to see if the new drug can stop the cancer from growing for longer.